Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : 2000-Year of the Biotechs! -- Ignore unavailable to you. Want to Upgrade?

To: Arthur Radley who wrote (220)	2/7/2000 10:01:00 PM
From: bluejeans	Respond to of 1142

TD, Hurry up and move to Hawaii. Too many folks posting on this thread seem to hate you right now for you to continue living in my state.;)

To: Arthur Radley who wrote (220)	2/7/2000 10:02:00 PM
From: Michael Young	Read Replies (3) \| Respond to of 1142

<<Humm! CELG has a 52 week low of $11...IDPH has a low of $19...UTHR has a low of $11 and HGSI has a low of $14. Were these "good" stocks at these price levels?>> Exactly!!! The biotech bull market came! Fund managers did their research and picked the best and brightest to send to the "moon." Kinda like being on the "A" list. Now some people are trying to push up the dregs, because they "haven't moved much yet." But there is a reason for that. It's because they are of lower quantity and have very limited "stamina." A lot of these biotechs are going to do great things and make some investors wealthy over the next few years. The market is telling us which stocks those are. We just have to listen. I'm not saying chase these high fliers. There will be some scary corrections to come in the group. But the winners will bounce back strong. The trash won't. I enjoy the debate. Currently long some CELG and UTHR . . . MIKE

To: Arthur Radley who wrote (220)	2/7/2000 10:24:00 PM
From: Jack Hartmann	Respond to of 1142

I remember when Genentech IPO'd. Took off like a rocket and has never been cheap. I noticed that many biotechs had double digits gains today. I see the news less and less on B2B as the best sector and more on biotechs. Bought GLFD today, good chart, improving revenues, decreasing losses, product in Phase III trials. Worth Magazine March 2000 cover features Mark Levin of Millennium Pharmaceuticals. Got the mag today, so good bet to rise some more. First time Worth featured a biotech company. Half the issue is biotech and the sector. Haven't read through it, but looks good on first scan. Calling this the "third wave" of the biotech rush. Jack